ARS Pharmaceuticals, Inc. (SPRY) Capital expenditures 2020–2025
ARS Pharmaceuticals, Inc. (SPRY) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$339,000FY2025 · since FY2020: $917,000 → $339,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $339,000 | -39.8% |
| FY2024 | $563,000 | +221.7% |
| FY2023 | $175,000 | -12.1% |
| FY2022 | $199,000 | +261.8% |
| FY2021 | $55,000 | -94.0% |
| FY2020 | $917,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice